Copies of the drug can be manufactured only after all the patents covering it expire, AstraZeneca’s counsel argued in court on Tuesday.from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2Lyzmy4
via IFTTT
AstraZeneca sues DRL on patent
Copies of the drug can be manufactured only after all the patents covering it expire, AstraZeneca’s counsel argued in court on Tuesday.from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2Lyzmy4
via IFTTT
0 comments:
Post a Comment